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Abstract




In survival studies, it is often of interest to study cure rates. Sometimes the event
of interest (such as death or the occurrence of a disease) may not be experienced by
individuals under study, and the cure rate is the probability of the latter eventuality.
Furthermore, survival times (i.e., the time to the event of interest) may be subject to
random censoring due to dropping out or late entry of individuals during the study
period. Interestingly, random censoring facilitates the estimation of the cure rate.
In this research, we study cure rates for multivariate survival times under multi-
variate random censoring. Specifically, three topics have been studied. In the first
topic of this thesis, a new non-parametric multivariate cure rate estimator, based on a
multivariate Kaplan-Meier estimator, is proposed. The asymptotic normality and an
estimator of asymptotic variance of this estimator are obtained. In the second topic,
a non-parametric cure rate estimator in the presence of covariates is constructed via
kernel smoothing. The asymptotic normality of this estimator is obtained, and the
optimal choice of the bandwidth via cross-validation is discussed. In the third topic of
this thesis, we develop a test for the presence of immunes, i.e., we test if the cure rate
is zero against the alternative that it is positive, under univariate random censoring.
The limiting distribution of the test statistic under the null hypothesis is obtained
using extreme-value theory. Theoretical results are supported by simulation studies.
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The main aim of survival analysis is modeling and analyzing time-to-event data.
Survival data consists of the occurrence of event of interest over time. The event
of interest could be death, occurrence of a disease, re-arrest of a released prisoner,
marriage, divorce, etc. The presence of immune individuals has an important role in
the analysis of survival data. We define the cured or immune individuals as the ones
who are not subject to the event of interest. Often our information on the survival
times of individuals is not complete because there is censoring in the study. Censoring
can happen due to loss of follow-up, drop out or termination of the study. There are
different types of censoring such as right, left and interval censoring. Right censoring
is the most common form of censoring. As an example of right censoring, we can refer
to a patient who does not experience the event of interest during study or drops out
of the study before the event could occur.
Left censoring happens when the event of interest has occurred before the entrance
of the person in the study. For example, if a person is asked at what age he used
marijuana first and he does not remember the exact age, such situation is considered
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as left censoring. A more general type of censoring is called interval censoring. It
occurs when the event occurs within an interval where the individual is not observed.
As an example, we can refer to the periodic follow-up of a patient in the study. It is
known that the event time falls in an interval between two follow-ups. The Kaplan-
Meier estimator provides a nonparametric estimate of distribution function of a time
to event variable in the presence of independent right censoring. As illustrate in [9],









where nj and dj are, respectively, the number of individuals at risk and the number
of those who fail at time tj and t1 ≤ ... ≤ tn are observed failure times. Maller and
Zhou [11] proposed the tail (i.e., ˆ¯F (tn)) of the Kaplan-Meier estimator as an estimator
of cure rate in the univariate case.
1.2 Objectives
The main objective of this research work is to construct and analyze non-parametric
cure rate estimators for multivariate survival times in the presence of multivariate
random censoring. Many examples of multivariate survival times have been studied
in the literature. For instance, Chen et al. [5] consider the following type of bivariate
survival times: (time to disease relapse, time to death) and (time to first infection,
time to second infection). In these cases, the non-occurrence of one or both of the
component events would be termed as cure.
First, we will consider the Maller-Zhou estimator and re-derive its asymptotics, but
without using martingale theory as in Maller and Zhou [11]. The estimator will then
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be extended to the multivariate case using a recently proposed multivariate Kaplan-
Meier estimator [18]. The asymptotic normality of the estimator will be established,
and its asymptotic variance will be estimated.
In the second step, our aim is to include, via kernel smoothing, the effect of covari-
ates in the multivariate cure rate model under random censoring. For this new model
with covariates, asymptotic normality of the proposed estimator and estimator of its
asymptotic variance will be derived. The optimal choice of the bandwidth will be
found through cross-validation.
In the third step, the presence of immunes will be tested under univariate random
censoring. The limiting distribution of the test-statistic will be obtained under the
null hypothesis of zero cure rate using extreme value theory.
In all three steps, a simulation study is conducted to support the mathematical
theory.
1.3 Organization of the Thesis
This section outlines the layout of this thesis. The thesis consists of five chapters.
In Chapter 1 (present chapter), a brief description of the problem is given. Chapter 2
is dedicated to the new nonparametric multivariate cure rate estimator with random
censoring. The asymptotic distribution of the proposed estimator and its variance
are also identified in Chapter 2. In Chapter 3, the covariates are included in the
model and a new nonparametric multivariate cure rate estimation with the effect of
the covariates is proposed and studied. In Chapter 4, the presence of immunes in
the univariate model is tested using the extreme value theory. In Chapter 5, a short
summary of this thesis is provided.
3
Chapter 2
Multivariate Cure Rate Estimation
under Random Censoring
2.1 Introduction
One of the popular and common studies in the survival analysis is analyzing survival
data with cure rate. Survival analysis is used for modeling and analyzing time to
event data and typically in survival data, an event is defined as death or failure.
During a study, individuals can be cured (cured of a disease or no warranty claim
for a car) or fail (death from a disease or claim for a warranty). Cured or immunes
are the individuals who are not subject to the event of interest. The cure rate is the
probability of being cured for an infected individual so in other words, p = P (X =∞)
where X is time to the event of interest.
There are two main univariate cure models in the literature. The first one is a
mixture model, F¯ (t) = P (X ≥ t) = p + (1 − p)F¯o(t), where F¯o(t) is the base-
line survival function. The second one is bounded cumulative hazard (BCH) model,
P (X ≥ t) = exp(− ∫ t
0
h(s)ds) such that 0 < p = exp(− ∫∞
0
h(s)ds) < 1, where
h(.) is the hazard rate. There are not many studies in the literature focusing on the
4
nonparametric cure rate estimation. One of the first studies in this field is Maller and
Zhou [11] who estimate the cure rate nonparametrically using the tail of Kaplan-Meier
estimator [10].
Chen et al. [5] proposed a Bayesian approach for a multivariate cure rates. They
used data from a melanoma clinical trial done by ECOG (Eastern Cooperative Oncol-
ogy Group) where X = (X1, X2), X1 is time to relapse after treatment and X2 is time
from relapse to death. A frailty term with a positive stable distribution is introduced
in their model to characterize the association between the failure times. They em-
phasized that sufficient follow-up of patients is crucial to their approach. They also
considered the effect of covariates in the model. However, their model is based on a
parametric approach and their model cannot be used for nonparametric approach. Xu
and Peng [24] obtained a nonparametric cure rate estimator incorporating the impact
of covariates. Their proposed estimator is consistent and asymptotically normal, but
it only handles the univariate cure rate.
Sen and Stute [18] proposed a multivariate Kaplan-Meier estimator, which was the
unique solution of an eigenfunction equation via a mass-shifting method. In this
paper, we use the tail (excess mass) of the Sen-Stute estimator as an estimator of
cure rates under multivariate random censoring, taking a cue from Maller and Zhou
[13]. The computation of our estimator is straightforward, unlike that of Chen et
al. [5]. Further, even though we use the sufficient follow-up condition to establish
asymptotic normality of our estimator, our simulation model violates this condition.
Yet the performance of our estimator is not affected. This shows that our estimator
is quite robust.
This manuscript is organized as follows. In Section 2.2, the asymptotic normality of
the Maller-Zhou estimator is established and its variance is estimated without using
martingale theory, unlike in Maller and Zhou [13]. In Section 2.3, the asymptotic
5
normality of the multivariate cure rate estimator is established and its variance esti-
mator is obtained. In Section 2.4, the results from Sections 2.2 and 2.3 are illustrated
using simulations. In Section 2.5, the model is applied on real data. In Section 2.6,
a short summary of the research work is given.
2.2 Univariate Cure Rate Estimator
In this section, the univariate cure rate estimator is considered. Let Xi, 1 ≤ i ≤ n,
be independent and identically distributed (iid), non-negative random variables, each
having a distribution function F(.) such that F (x) = P{X ≤ x} = (1 − p)Fo(x).
The survival function gives the probability of surviving beyond a specific time. It
is defined as F¯ (x) = P{X ≥ x} = p + (1 − p)F¯o(x). Due to the limited study
time, the Xi’s may not be observed. So in this case, there will be censoring variables
Yi, 1 ≤ i ≤ n, an independent set of iid random variables with distribution function
G(.), so that only (δi, Zi), 1 ≤ i ≤ n, can be observed where δi = 1{Xi ≤ Yi} and
Zi = min(Xi, Yi) (1(A) indicates the indicator function of event A).
Define,
H1 (t) = E (δ 1 (Z ≤ t)) = (1− p)
∫ t
0
G¯ (s)Fo (ds) , (1)
H¯ (t) = P (Z ≥ t) = ((1− p) F¯o (t) + p) G¯ (t) . (2)










1(Zi ≥ t). (3)
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the Kaplan-Meier estimator at the largest observation. Below we establish consis-
tency and asymptotic normality of pˆ, but avoiding martingale arguments of Maller
and Zhou [13]. Although for the sake of convenience, the absolute continuity of Fo
and G are assumed.
Theorem 1 Suppose Fo and G are absolutely continuous and satisfy the sufficient
follow-up assumption (τFo ≤ τG where τFo and τG are the right extremes of Fo and
G, respectively, i.e, τFo = sup(t ≥ 0 : F0(t) < 1)), then
√
n(pˆ − p) is asymptotically
Normal with mean zero and limit variance




(p+ (1− p)F¯o(x))2G¯(x) ,





(n− i+ 1)2 ,
where δ[i:n] is (the concomitant) attached to the i-th order statistics Zi:n, 1 ≤ i ≤ n.
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and E(ψ(Zi)) = 0. Hence using the Central Limit Theorem
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is asymptotically normal. Taking variance of both sides of Eq.(5) gives us,
var(
√










































































(n− i+ 1)2 . (6)
From the ∆-method, we know that if X¯n has an asymptotic normal distribution
such that
√
n(X¯n − µ)→ N(0, σ2),
in distribution as n→∞, and assuming g has a derivative g′ at µ, and g′(µ) 6= 0,
then
√
n(g(X¯n)− g(µ))→ N(0, (g′(µ))2σ2).






(n− i+ 1)2 . (7)

2.3 Multivariate Cure Rate Estimator
Let X and Y be two independent m-dimensional random vectors with distribution
functions F and G respectively, where G is the censoring distribution. Let Zji =
min(Xji, Yji) and δji = 1(Xji ≤ Yji) for 1 ≤ i ≤ n and 1 ≤ j ≤ m. The survival
10
function of X is defined as F¯ (x) = F¯ (x1, . . . , xm) = P{X1 ≥ x1, . . . , Xm ≥ xm} =
P (X ≥ x), where the inequality is coordinatewise, here as well as in the rest of the
paper. To estimate F¯ , Sen and Stute [18] employed a mass-shifting technique. In this
paper, we use the mass-shifting method to find the estimator for F¯ . This method





X with probability 1− ε
x∞ with probability ε
where X is a multivariate vector. x∞ is a vector, possibly (∞, ...,∞) which exceeds
all (x1, ..., xm) componentwise, x ≤ x∞ ≤ ∞ and 0 < ε < 1. The survival function of
Xε can be written as
F¯ε(x1, ...xm) =
{
(1− ε)F¯ (x1, ...xm) + ε if (x1, ...xm) ∈Rm
ε if x∞ = (x1, ...xm)




I(t ≥ x, t 6= x∞)F¯ε(t) (1− ε)F (dt)
(1− ε)F¯ (t) + ε + ε.
The survival function of the defective model is F¯p(t) = (1 − p)P (X ≥ t) + p =
(1− p)F¯ (t) + p where F¯ (t) is the baseline survival function and F¯p(∞) = p.
Let F¯ε,p(t) be a defective survival function with cure rate p which takes the value
of x∞ with a probability of ε,
F¯ε,p(t) = (1− ε)F¯p(t) + ε.
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Then (F¯ε,p(t), F¯ε,p(∞)) for t ≥ 0, is the unique solution [18] to
F¯ε,p(x) =
∫
I(t ≥ x, t 6=∞)F¯ε,p(t) F¯ε,p(dt)
F¯ε,p(t)
+ F¯ε,p(∞), F¯ε,p(0) = 1. (8)
By iteration of Eq.(8), we obtain
F¯ε,p(x) = F¯ε,p(∞) + F¯ε,p(∞)
∫












1(tk ≥ ... ≥ t1 ≥ x, tk 6=∞) (1− ε)(1− p)F (dt1)
(1− ε)F¯p(t1) + ε ...
(1− ε)(1− p)F (dtk)
(1− ε)F¯p(tk) + ε
)
,
since F¯ε,p(0) = 1, then




























Note that the mass-shifting technique ensures a unique solution [18]. The empirical
version of Eq.(8) is
F¯ε,n(x) =
∫
1(t ≥ x, t 6=∞)F¯ε,n(t) (1− ε)H
1
n(dt)












1(Z1i ≥ t1, ..., Zmi ≥ tm).
Following Sen and Stute’s work [18], Eq.(11) can be written in the following eigen-
vector form and has a unique solution,
ABF¯ = F¯, bT F¯ = 1,
where F¯ = (F¯1, F¯2, ..., F¯n, F¯n+1), A = ((aij))1≤i,j≤n+1, B = diag(b1, ..., bn, bn+1),
b = (b1, ..., bn, bn+1), and for 1 ≤ i, j ≤ n,







, bn+1 = 1,
Sen and Stute [18] proposed F¯ε,n(.) as the multivariate Kaplan-Meier estimator.
Note that in 1 dimension (i.e., m = 1) with ε = 0, this estimator reduces to the
univariate Kaplan-Meier estimator. Here we propose F¯ε,n(∞) = F¯n+1 as the cure
estimator pˆn, extending the Maller-Zhou estimator to the multivariate case. The
choice of ε = 1
n+1
appears to be a natural choice.
Under random censoring, define
F¯ oε,p(x) =
∫
1(t ≥ x, t 6=∞)F¯ oε,p(t)
(1− ε)H1p (dt)
(1− ε)H¯p(t) + ε + F¯
o
ε,p(∞), (12)
where F¯ oε,p(0) = 1, H
1
p (dt) = G¯(t)Fp(dt) and H¯p(t) = G¯(t)F¯p(t).
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Theorem 2 Assuming Supp F ⊆ Supp G, F¯ε,n(x) − F¯ oε,p(x) has the asymptotic
representation
√
n(F¯ε,n(x)− F¯ oε,p(x)) = Ln(x) + op(1), 0 ≤ x ≤ ∞
where Ln(x) is given by
Ln(x)−
∫





1(t ≥ x, t 6=∞)αn(dt), x 6=∞
−
∫





1(t ≥ 0, t 6=∞)αn(dt), x = 0
where







, t ≥ 0.





n(F¯ε,n(x)− F¯ oε,p(x)) =
∫




(1− ε)H¯n(t) + ε −
(1− ε)H1p (dt)




1(t ≥ x, t 6=∞)√n(F¯ε,n(t)− F¯ oε,p(t))
(1− ε)H1p (dt)
(1− ε)H¯p(t) + ε +
√
n(F¯ε,n(∞)− F¯ oε,p(∞)), (13)
since we know F¯ε,n(0) = F¯
0
ε,p(0) = 1 by iterating Eq.(13), we obtain
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√




























(1− ε)H¯n(t) + ε −
(1− ε)H1p (dt)
(1− ε)H¯p(t) + ε
)
,
and consequently, by replacing Eq.(14) in Eq.(13) and iterating it, we get
√








(1− ε)H¯p(tj) + ε ,
where 1u = 1(tk ≥ ... ≥ t1 ≥ u, tk 6=∞).
Now it may be verified that if we choose ε = o( 1√
n
), (e.g., ε = 1
n+1
), then as n→∞,
√





1(t ≥ x, t 6=∞)αn(dt) + op(1),


















1(t ≥ 0, t 6=∞)αn(dt). (15b)

The asymptotic covariance function of Lx is denoted by Vxy = E(Ln(x)Ln(y)). To
obtain the covariance function, first we rewrite Eq.(15a-b) for y,
Ln(y)−
∫





1(s ≥ y, s 6=∞)αn(ds), (16a)
−
∫





1(s ≥ 0, s 6=∞)αn(ds). (16b)
We know
∫







1{Zi ≥ t ≥ x}F (dt)
H¯(t)
)
for all x ≥ 0,
so multiplying for x, y ∈ IR2+ := [0,∞) × [0,∞) and taking expectation give us the















































Multiplying Eq.(15a)× Eq.(16a), Eq.(15a)× Eq.(16b), Eq.(15b)× Eq.(16a), Eq.(16b)









1(s ≥ y, s 6=∞)Vxs
H1p (ds)
H¯p(s)
− Vx∞ − Vy∞
+
∫ ∫












1(s ≥ y, s 6=∞)Vs∞
H1p (ds)
H¯p(s)
+ V∞∞ = Axy, (18a)
−
∫

















1(t ≥ x, t 6=∞)Vt∞
H1p (dt)
H¯p(t)
+ V∞∞ = Ax0, (18b)
−
∫

















1(s ≥ y, s 6=∞)Vs∞
H1p (ds)
H¯p(s)
+ V∞∞ = A0y, (18c)
∫ ∫












1(s ≥ 0, s 6=∞)Vs∞
H1p (ds)
H¯p(s)
+ V∞∞ = A00. (18d)
Matrix Form We estimate Vxy by Vˆxy = Vij at x = Zi and y = Zj, for 1 ≤ i, j ≤
n+ 1 where Zn+1 = x∞ and Vn+1,n+1 = Vˆ∞,∞ = Vˆ (pˆn). Let A, B and b be as before,
and let I¯F = diag(F¯1, . . . , F¯n). Define the matrix D = ((dij))1≤i,j≤n as
18
dij = (1− aij)(1− aji)
n∑
r=1
airajr, 1 ≤ i, j ≤ n.
Then the sample version of Eqs.(18a-d) can be written as
 (I−AB)
−bT




 (I+BnDBn) [ I¯F (BA)Tn×n I¯Fbn ] ,
where bn is a subvector of b with first n elements and matrices of Bn and (AB)n×n
are submatrices of matrix B and matrix AB, respectively, with the first n rows and






 (I+BDB) [ I¯FBAT I¯Fb ] [ (I−AB)T −b ]− ,












Univariate Case: In this section, a simulation study is conducted. We first gener-
ate n independent random variables, Xi, 1 ≤ i ≤ n from an exponential distribution
with mean of m1 and n independent random censored times, Yi, 1 ≤ i ≤ n from an
19
exponential distribution with mean of m2. Xi and Yi are chosen to be dependent of
each other. The cure rate p is assumed to be known and u is generated from the
uniform (0,1) distribution. δ1 is generated as a binary variable (if u > p and X1 ≤ Y1
then δ1 ≡ 1, otherwise δ1 ≡ 0). Using Eq.(7) and setting m1 = 2, m2 = 4 and
different values for n and p, we got Table 1.
Sample size n=100 n=200 n=500
p=0 pˆ 0.01553 0.01000 0.00655
ˆvar 0.00029 0.00001 0.00005
MSE 0.00095 0.00035 0.00018
p=0.25 pˆ 0.25846 0.25436 0.25315
ˆvar 0.00422 0.00243 0.00115
MSE 0.00719 0.00294 0.00152
p=0.5 pˆ 0.50324 0.50168 0.49890
ˆvar 0.00533 0.00289 0.00120
MSE 0.00651 0.00337 0.00104
Table 1: Table of univariate cure rate estimators (for different n and p)
Bivariate Case: To run a bivariate simulation study, the independent random
vectors of Sij, Tij and Dij for 1 ≤ i ≤ n and j = 1, 2 with following densities are
generated
Si1 ∼ exp(λ1 − c1), Si2 ∼ exp(λ2 − c1), Di1 ∼ exp(c1),
Ti1 ∼ exp(λ3 − c2), Ti2 ∼ exp(λ4 − c2), Di2 ∼ exp(c2).
Then Xi1, Xi2, Yi1 and Yi2 are generated as the following such that Xi1 and Xi2,
and Yi1 and Yi2 are dependent:
20
Xi1 = min(Si1, Di1) ∼ exp(λ1), Xi2 = min(Si2, Di1) ∼ exp(λ2),
Yi1 = min(Ti1, Di2) ∼ exp(λ3), Yi2 = min(Ti2, Di2) ∼ exp(λ4).
So, we can easily obtain that the survival function of a defective model is
F¯p(xi1, xi2) = (1− p)exp(−λ1xi1 − λ2xi2 − c1max(xi1, xi2)) + p, for i = 1, ..., n.
A random sample with λ1 = 0.4, λ2 = 0.4, λ3 = 0.15, λ4 = 0.15, c1 = 0.1
and c2 = 0.1 with different values of n are generated 100 times. After running the
simulation, we got the estimated cure rate, its estimated variance and its MSE for
different n and p which are shown in Table 2.
Sample size n=100 n=200 n=500
p=0 pˆ 0.05802 0.03523 0.01956
ˆvar 0.00021 0.00079 0.00023
MSE 0.00397 0.00139 0.00045
p=0.25 pˆ 0.28098 0.26836 0.25746
ˆvar 0.00648 0.00360 0.00176
MSE 0.00756 0.00340 0.00205
p=0.5 pˆ 0.53117 0.49564 0.50668
ˆvar 0.00794 0.00439 0.00173
MSE 0.00672 0.00390 0.00211
Table 2: Table of bivariate cure rate estimators (for different n and p)
Both univariate and bivariate results show that our estimator’s performance is
great for moderate to large sample size. The pˆ is very close to p and the variances
and MSE’s are very close to each other.
In Fig. 1, the plots show the bivariate surface of F¯ (left) and its estimation F¯n
(right) for one simulated data set. p is assumed to be 0.25.
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Figure 1: The bivariate surface of F¯ (left) and its estimation F¯n (right)
Fig. 1 shows that F¯ and F¯n are very similar and the values are very close to each
other.
2.5 Illustration of the Model through Real Data
We applied our proposed model to the data from the Litter-matched tumorigenesis
experiment [14]. In this study, 150 rats were divided into three different groups,
control 1, control 2 and drug-treated. The event of interest is considered as tumor
appearance. Any death due to other causes are considered as censoring. The length
of the study is 104 weeks. For our model, we applied some modifications to their
data to use it for a bivariate model. For our study, the drug-treated group is ignored,
the control 1 is considered as X1 and the control 2 is considered as X2. Our goal is
to estimate the probability of a cure among rats with a tumor. The Kaplan-Meier
survival estimate is shown in Fig. 2 to show the possible presence of cured patients.
The cure rate is estimated around 0.9024 and the estimated variance is equal to 0.003.
22
Figure 2: The Kaplan-Meier plot for control 1 (left) and control 2 (right).
2.6 Conclusion
In this research work, we have proposed a new multivariate cure rate model and
have examined several of its properties. In this new approach, the tail of the Sen-
Stute estimator has been used for the estimation of the cure rate. The asymptotic
normality of this estimator has been obtained under the sufficient follow-up condition.
One of the advantages of this model is that the proposed estimator is quite robust,
its calculation is not complicated and it can handle both univariate and multivari-
ate cases. For ease and clarity of exposition, we conducted a simulation study for
univariate and bivariate cure rate estimators.
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Rate Estimation with Covariates
3.1 Introduction
One of the popular and common studies in the survival analysis is survival data
with cure rate. In survival analysis, a proportion of the population may be cured, i.e.,
will not experience the event of interest under study, such as death, disease onset,
etc. On the other hand, survival data is often subject to random censoring which
can happen due to reasons such as loss to follow-up, drop-out and limited study
period. In this chapter, we consider the estimation of the conditional cure-rate, i.e.,
cure-probability as a function of covariates, under multivariate random censoring.
Let Ui, 1 ≤ i ≤ n, be independent and identically distributed (iid), non-negative
random vectors, each having a marginal distribution function F (u) = P (U ≤ u) and
survival function F¯ (u) = P (U ≥ u). A proportion of individuals cured because of
covariates, are considered in the model. Since a proportion of individuals are cured,
the conditional survival function is defective and it has the following form
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F¯0(u|c) = P (U ≥ u|U <∞, C = c),
pi(c) = P (U =∞|C = c),
where C is the vector of covariates and pi(c) is the conditional cure rate which
depends on the covariates. The overall conditional survival function therefore has the
following mixture model form:
F¯ (u|c) = P (U ≥ u|C = c) = pi(c) + (1− pi(c))F¯0(u|c).
Beran [1] considered univariate conditional Kaplan-Meier estimators in the presence
of covariates and censoring. Beran [1] and Dabrowska [6] studied the asymptotic
distribution and uniform consistency for the kernel and nearest neighbour estimates
of the survival function.
Nieto-Barajas and Yin [15] studied a Bayesian semiparametric model with cure
rates. They proposed a model in which each individual’s cure time can be different
depending on the parametrically modelled covariates.
Tsodikov [21] used the proportional hazard model to find the effect of covariates on
the cure rate in a non-parametric framework. One of the disadvantages of his method
is that it is only applicable on discrete covariates.
Xu and Peng [24] proposed a fully non-parametric estimator for the cure rate with
covariates. Following Maller and Zhou [11], they used the conditional Kaplan-Meier
estimator of Beran [1] at the largest uncensored failure time to find a consistent and
asymptotically normal estima for conditional cure rate. They considered the effect
of one and more than one covariates on the model, although the survival time is
univariate.
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Chen et al. [5] developed a Bayesian estimator for multivariate cure rates in the
presence of right censoring, based on a parametric model. In their proposed model,
the proportional hazard model is used to estimate the effect of covariates on the
cure rate. However, no non-parametric cure-rate estimator seems to exist in the
multivariate set-up.
In this chapter, we propose a new non-parametric multivariate cure rate estimator
in the presence of multivariate censoring and covariates. Our estimator thus extends
the estimator of Xu and Peng [24] to the case of multivariate survival time and reduces
to the latter in the univariate case. The estimator is obtained by introducing kernel
smoothing into the fundamental eigenvector equation of the previous chapter.
In Section 3.2, the smoothing equation is introduced and a nonparametric multi-
variate cure rate estimator in the presence of covariates is obtained. In Section 3.3,
the asymptotic distribution of the proposed estimator is obtained. In Section 3.4,
the estimated covariance function has been obtained along with optimal order and
choice of bandwidth via cross-validation. A simulation study of the proposed model
is conducted in Section 3.5. A brief conclusion and discussion are provided in Section
3.6.
3.2 Nonparametric Multivariate Cure Rate Esti-
mator with Covariates
Let X and Y be independent m and r-dimensional random vectors with distribution
functions F and G, respectively, where X = (U,C) = (U1, . . . , Ur, C1, . . . , Cs), r+s =
m, r ≥ 1, s ≥ 1, are random variables such that U is subject to censoring and
C is the s dimensional vector of covariates which is not subject to censoring. Let
Y = (Y1, . . . , Yr) be the censoring variable. We assume the conditional distribution
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of U |C = c, is given by
(1− pi(c))fU |C(u|c) 0 ≤ u <∞ [conditional density],
pi(c) = P (u =∞|c) u =∞ [mass point].
In other words, the finite (i.e., non-cured) part of the conditional distribution is
given by a conditional density. Further, assuming C has a density, the joint distribu-
tion of U and C is given by
(1− pi(c))fU,C(u, c) 0 ≤ u <∞, 0 ≤ c <∞,
pi(c)fC(c) u =∞, 0 ≤ c <∞,
and the marginal distribution of U is given by
∫
(1− pi(c))fU |C(u|c)fC(c)dc 0 ≤ u <∞,∫
pi(c)fC(c)dc = p u =∞.
Our aim is to estimate the conditional cure-rate function pi(c).
Assume Wj = min(Uj, Yj) and ηj = I(Uj ≤ Yj) for j = 1, . . . , r so (Z, δ) are
observable under random censoring, where δ = (η1, . . . , ηr, 1, . . . , 1) and Z = (W,C) =
(W1, . . . ,Wr, C1, . . . , Cs) are m-dimensional vectors. Note again that C = (C1, ..., Cs)
is uncensored. Our estimation is based on sample size of n.
Let F¯ pi(u|c) be the defective conditional survival function with cure rate pi(c), i.e.,
F¯pi(u|c) = (1− pi(c))F¯U |C(u|c) + pi(c),
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then it is the unique solution to the following equation
F¯pi(u|c) =
∫
I(u ≤ t <∞)F¯pi(t|c)Fpi(dt|c)
F¯pi(t|c) + F¯pi(∞|c) 0 ≤ u <∞,
where F¯ pi(∞|c) = pi(c) and F¯ pi(0|c) = 1.
To find smooth structure in the data, kernel smoothing is commonly used in the







where Kn(x−Xi) = 1hsnK(
x−Xi
hn
) and K(.) is a non-negative, s-variate kernel function




K(x)dx = 1 and hn is
the bandwidth satisfying, as n→∞, hn → 0 and nhsn →∞ [23].
If ϕ(U) be an arbitrary function of U , we have
E(ϕ(U)Kn(c− C)) =
∫




If the bandwidth approaches zero, the equation above becomes (all the limit state-
ments below assume appropriate smoothness and integrability conditions, to be speci-
fied later):
E(ϕ(U)Kn(c− C)) hn→0−−−−→ (1− pi(c))fC(c)
∫
ϕ(u)I(0 ≤ u <∞)fU |C(u|c)du+ ϕ(∞)pi(c)fC(c)
= fC(c)E(ϕ(U)|C = c).
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Further, by taking ϕ(U) = I(U ≥ u),
E(I(U ≥ u)Kn(c− C)) hn→0−−−−→ (1− pi(c))fC(c)F¯U |C(u|c) + pi(c)fC(c) = fC(c)F¯pi(u|c). (20)
For the censored data, define the empirical processes as
∫









Kn(c− Ci)I(Wi ≥ w),
which are kernel weighted versions of Hn1(.) and H¯n(.), respectively, of the previous
chapter. Here, as before, η = η1η2...ηr. Note that
∫






G¯(u)ϕ(u)I(0 ≤ u <∞)Kn(c− c′)(1− pi(c′))fU |C(u|c′)fC(c′)dudc′, (21)
so that
∫
ϕ(w)H1(dw|c, hn) hn→0−−−−→ fC(c)E
(













ϕ(w)I(0 ≤ w <∞)Fpi(dw|c)
F¯pi(w|c) , (24)
and it follows that we may use the unique solution (F¯n(u|c, hn), 0 ≤ u <∞, pin(c))
of the following equation as estimators of (F¯pi(u|c), 0 ≤ u <∞, pi(c)):
F¯n(u|c, hn) =
∫
I(u ≤ t <∞)F¯n(t|c, hn) (1− ε)Hn1(dt|c, hn)
(1− ε)H¯n(t|c, hn) + ε + pin(c) 0 ≤ u <∞, (25)
where F¯n(0|c, hn) = 1 and ε > 0 is a sufficiently small mass-shifting parameter
(below we take ε = 1
n+1
, as before). For convenience of comparison, we recall the
equation for (F¯pi(u|c), 0 ≤ u <∞, pi(c)) :
F¯pi(u|c) =
∫
I(u ≤ t <∞)F¯pi(t|c)Fpi(dt|c)
F¯pi(t|c) + pi(c) 0 ≤ u <∞, F¯pi(0|c) = 1. (26)
Eq.(25) can be re-written as the following eigenvector equation,
ABCF¯ = F¯, b
T
C F¯ = 1, (27)
where for 1 ≤ i, j ≤ n, F¯ = (F¯1, ..., F¯n, F¯n+1),A = ((aij)),BC = diag(b1(c), ..., bn(c), 1),
b(c) = (b1(c), ..., bn(c), 1) and aij = I(Zj ≥ Zi) = I(Wj ≥ Wi, Cj ≥ Ci), ai,n+1 =
an+1,n+1 = 1, an+1,j = 0,
bi(c) =
(1− ε) ηinhsK( c−Cih )
(1− ε)∑nk=1 aik 1nhsK( c−Ckh ) + ε . (28)
Note that pin(c) = F¯n+1 and the inequalities are coordinate-wise, i.e., I(Zj ≥ Zi) =
I(Zjk ≥ Zik, 1 ≤ k ≤ m).
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3.3 Asymptotic Properties
In this section, we first aim to find the expressions for F¯n(u|c, hn) − F¯pi(u|c) and
pin(c)− pi(c) as below. Note that
F¯n(u|c, hn)− F¯pi(u|c) =
∫
I(u ≤ t <∞)F¯n(t|c, hn)
( (1− ε)Hn1(dt|c, hn)
(1− ε)H¯n(t|c, hn) + ε −
(1− ε)H1(dt|c, hn)




I(u ≤ t <∞)[F¯n(t|c, hn)− F¯pi(t|c)] (1− ε)H1(dt|c, hn)
(1− ε)H¯(t|c, hn) + ε+
∫
I(u ≤ t <∞)F¯pi(t|c)
( (1− ε)H1(dt|c, hn)




+ [pin(c)− pi(c)]. (29)
Eq.(29) can be re-written as
[F¯n(u|c, hn)− F¯pi(u|c)]−
∫
I(u ≤ t <∞)[F¯n(t|c, hn)− F¯pi(t|c)]Λ(dt|c, hn)(c)− [pin(c)− pi(c)]
=
∫
I(u ≤ t <∞)F¯n(t|c, hn)αn(dt|c, hn) +
∫
I(u ≤ t <∞)F¯pi(t|c)α(dt|c, hn),
F¯n(0|c, hn)− F¯pi(0|c) = 0, (30)
where
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αn(dt|c, hn) = (1− ε)Hn1(dt|c, hn)
(1− ε)H¯n(t|c, hn) + ε −
(1− ε)H1(dt|c, hn)
(1− ε)H¯(t|c, hn) + ε ,
α(dt|c, hn) = (1− ε)H1(dt|c, hn)
(1− ε)H¯(t|c, hn) + ε −
Fpi(dt|c)
F¯pi(t|c) ,
Λ(dt|c, hn) = (1− ε)H1(dt|c, hn)
(1− ε)H¯(t|c, hn) + ε .




























Now using F¯n(0|c, hn)− F¯pi(0|c) = 0, we get






I(0 ≤ t1 ≤ ... ≤ tk <∞)[F¯n(tk|c, hn)αn(dtk|c, hn)











I(0 ≤ t1 ≤ ... ≤ tk <∞)Λ(dt1|c, hn)...Λ(dtk|c, hn)
)−1
. (32)
Eqs. (31) and (32) are the key to establishing asymptotic properties –consistency
and asymptotic normality– of (F¯n(.|c, hn)− F¯pi(.|c)) and (pin(c)− pi(c)).
First we list some basic convergence results, involving Hn1(.|c, hn), H¯n(.|c, hn), in
the following lemma whose proof is easy:
Lemma 1 Assume that
(A1) K(.) is a product-kernel, i.e., of the form K(x1, ..., xs) = K0(x1)...K0(xs),





K20 (x)dx =: R(K0) <∞.
(A2) The s-variate marginal and conditional densities fC(c) and fU |C(.|c), respec-
tively, as well as the cure-rate function pi(c) are twice continuously differentiable at
c.
Suppose E(ϕ2(W )) <∞ and n→∞,
(a) if hn → 0 and
∑∞











|H¯n(w|c, hn)− fC(c)G¯(w)F¯pi(w|c)| → 0,
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for each 0 ≤ c <∞, with probability one.






ϕ(U)G¯(U)I(0 ≤ U <∞)|C = c))→ N(0, σ2(ϕ, c))
in distribution, where
σ2(ϕ, c) := (R(K0))
sfC(c)E
(











in distribution, for each 0 ≤ c <∞, 0 ≤ w.
Proof: Note that both
∫
ϕ(w)Hn1(dw|c, hn) and H¯n(w|c, hn) are averages of iid
random variables, and the condition
∑∞
n=1 exp(−ρnhsn) <∞ for ρ > 0 implies nhsn →
∞.
The proofs of Parts (a) and (b) follow by standard methods used in curve smoothing
literature, i.e., splitting each difference into random and bias terms, then calculating
variance of the random part and finally using Taylor’s expansion on both variance
and bias terms. See, for instance, Wand and Jones [23]. In particular, the uniform
convergence in Part (a), (ii), follows from Theorem 1 of Stute [20].





I(u ≤ t <∞)F¯pi(t|c)(nhsn)1/2
( (1− ε)Hn1(dt|c, hn)
(1− ε)H¯n(t|c, hn) + ε −
(1− ε)H1(dt|c, hn)




I(u ≤ t <∞)F¯pi(t|c)(nhsn)1/2αn(dt|c, hn) 0 ≤ u <∞, (33)
converges in distribution, as n→∞, to the mean-zero Gaussian process D(u|c), 0 ≤
u <∞, with covariance function














H¯(max(W1,W2))(1− I(W1 ≥W2))(1− I(W1 < W2))).
I(u ≤W1 <∞, v ≤W2 <∞)|C = c
))
0 ≤ u, v <∞,








((1− ε)H¯(t|c, hn) + ε)Hn1(dt|c, hn)− ((1− ε)H¯n(t|c, hn) + ε)H1(dt|c, hn)
)
((1− ε)H¯n(t|c, hn) + ε)((1− ε)H¯(t|c, hn) + ε) .
Next, note that tightness of Dn(.|c) follows from that of Dn(0|c), and the latter
follows by the facts that F¯pi(.|c) is bounded and H¯n(t|c, hn) in the denominator of the
integrand can be replaced, by Lemma 1(a), (ii), by fC(c)G¯(t)F¯pi(t|c.) Further, once
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we make this replacement the expression for the limiting covariance function follows
by Lemma 1(b) and elementary covariance calculations.

Theorem 3 Denote
Ln(u|c) := (nhsn)1/2(F¯n(u|c, hn)− F¯pi(u|c)),
Ln(∞|c) := (nhsn)1/2(pin(c)− pi(c)).
Then under the conditions of Lemma 1(a), (Ln(u|c), u ≥ 0, Ln(∞|c)) converges in




I(u ≤ t <∞)L(t|c)Fpi(dt|c)
F¯pi(t|c) − L(∞|c) = D(u|c) u ≥ 0,
L(0|c) = 0↔ −
∫
I(0 ≤ t <∞)L(t|c)Fpi(dt|c)
F¯pi(t|c) − L(∞|c) = D(0|c). (34)





I(u ≤ t <∞)Ln(t|c)Λ(dt|c, hn)− Ln(∞|c)
=
∫
I(u ≤ t <∞)F¯n(t|c)(nhsn)1/2αn(dt|c, hn)
+
∫
I(u ≤ t <∞)F¯pi(t|c)(nhsn)1/2α(dt|c, hn) 0 ≤ u <∞,
Ln(0|c) = 0 n ≥ 1. (35)
It then follows by Lemma 2 that the process (Ln(u|c), u ≥ 0, Ln(∞|c)) is tight,
since F¯n(.|c, hn) is bounded, and Eq.(31) and Eq.(32) show that Eq.(35) is invertible.
Note that the second term on the right hand side of Eq.(35) is non-random and tends
to 0, as n → ∞ by Taylor expansion arguments similar to those in the proof of
Lemma 1. Further, the latter also means that Eq.(24) holds, i.e.,
Λ(dt|c, hn)→ Fpi(dt|c)
F¯pi(t|c) as n→∞.
By the above arguments, we conclude from Eq.(35), Lemma 2 and Theorem 3.3.1,
p.310, of van der Vaart and Wellner [22] that the limit (L(u|c), 0 ≤ u < ∞, L(∞|c))
satisfies Eq.(34).

Corollary 1 Denote by τ(., .|c), the covariance of the limiting Gaussian process
(L(u|c), u ≥ 0, L(∞|c)) in Theorem 3, i.e.,
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τ(u, v|c) = E(L(u|c)L(v|c)) 0 ≤ u, v ≤ ∞.
Further, define the measure
Λpi(dt|c) = Fpi(dt|c)
F¯pi(t|c) 0 ≤ t <∞, Λpi(∞|c) = 1.
Then τ(., .|c) is determined by the following equations:
τ(u, v|c)−
∫
I(t ≥ u)τ(t, v|c)Λpi(dt|c)−
∫
I(s ≥ v)τ(u, s|c)Λpi(ds|c)
+
∫ ∫
I(t ≥ u, s ≥ v)τ(t, s|c)Λpi(dt|c)Λpi(ds|c) = σ(u, v|c),
−
∫
I(s ≥ 0)τ(u, s|c)Λpi(ds|c) +
∫ ∫
I(t ≥ u, s ≥ 0)τ(t, s|c)Λpi(dt|c)Λpi(ds|c) = σ(u, 0|c),
−
∫
I(t ≥ 0)τ(t, v|c)Λpi(dt|c) +
∫ ∫
I(t ≥ 0, s ≥ v)τ(t, s|c)Λpi(dt|c)Λpi(ds|c) = σ(0, v|c),
∫ ∫
I(t ≥ 0, s ≥ 0)τ(t, s|c)Λpi(dt|c)Λpi(ds|c) = σ(0, 0|c), (36)
where σ(., ., c) is the covariance function in Lemma 2.
Proof: Follows by writing Eq.(34) once each for u ≥ 0 and v ≥ 0, then multiplying
the two and taking expectation on both sides. Note that Eq.(36) can in fact be
explicitly solved for τ(., .|c) by the iteration technique leading to Eqs.(31) and (32).

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3.4 Estimated Covariance Function
We now obtain the empirical version of Eq.(36) by replacing every function by its
empirical version, which necessarily has jumps at sample values, referring to Eqs.
(27) and (28).
On the left-hand side of Eq.(36), note that
Λpi(dt|c) = Fpi(dt|c)
F¯pi(t|c) 0 ≤ t <∞, Λpi(∞|c) = 1,
can obviously be estimated, at t = Zi and t =∞, by
(1− ε)Hn1(dt|c, hn)
(1− ε)H¯n(t|c, hn) + ε = bi(c), 1 ≤ i ≤ n, and bn+1(c) = 1,
respectively. On the right-hand side, σ(u, v|c) can be estimated at u = Zi and






































and so on, where
dkl = (1− akl)(1− alk)
n∑
r=1
akralr 1 ≤ k, l ≤ n.
40
Hence, denoting the matrices
V = ((τˆ(Zi, Zj |c)))1≤i,j≤n+1,D = ((dij))1≤i,j≤n, F¯ = diag(F¯1, ..., F¯n),
where Zn+1 =∞, and using the notation of Eqs. (27)-(28), we get the equation
 I−ABc
−bTc
V [ (I−ABc)T −bT ] =
 A0B0cF¯
bT0cF¯
 (I+B0cDB0c) [ F¯B0cAT0 F¯b0c ] ,
where T denotes the matrix transpose, A0, B0c are obtained by deleting the (n+1)-
st row and column of A, Bc, respectively, and b0c is obtained from bc by deleting its
(n+ 1)-st component (which is 1).
3.4.1 Optimal Order of Bandwidth hn
From Eq.(30), it is clear that the convergence of (F¯n(.|c, hn)− F¯pi(.|c), pin(c)−pi(c))
is controlled by the random part (’variance’ term)
vn :=
∫
I(u ≤ t <∞)F¯pi(t|c, hn)αn(dt|c, hn),
and the deterministic part (’bias’ term)
Bn =
∫
I(u ≤ t <∞)F¯pi(t|c, hn)α(dt|c, hn).
















which is the usual optimal order in kernel-smoothing.
3.4.2 Optimal Choice of hn via Cross-Validation
One of the common ways to find the optimal hn is minimizing the mean integrated













where fˆj is the kernel density estimator with j-th observation deleted from sample.
We propose to make an optimal, data-based choice of hn via cross-validation,





where piin(c) is the estimator of pi(c) obtained from the same sample, but with i−th
data-point deleted, i.e., piin(c) is based on (δj, Zj, j 6= i) for 1 ≤ i ≤ n.
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3.5 Simulation
In this section of thesis, a simulation study is conducted to see how the theory works
on the data. For the ease of calculation and make it more visual, we assume that
there is only one covariate in the model. A sample of n = 100 independent random
variables Ci (covariates) from Exponential(1) has been generated. Variables Xi’s are
dependent on the covariates and they follow the distribution function Exponential(c).
Censoring variables Yi’s are generated from the distribution of Exponential(0.2). The
cure rate function is taken to be pi(c) ≡ exp(− exp(−c)). Figure 3 shows the behaviour
of cure rate estimator versus different values of covariate. The red and blue dots show
the cure rate and the cure rate estimator using the proposed nonparametric model,
respectively.
Figure 3: Cure rate estimation for different value of covariates
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Using the cross-validation method, for a fixed value of c = 0.2952, different band-
widths have been chosen for the model. Based on the smallest CVn, the best band-
width is chosen as h = 0.2.
Bandwidth 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
CVn 0.2772 0.2067 0.2144 0.2359 0.2712 0.3066 0.3322 0.3470 0.3543 0.3584
Table 3: Table of CVn values based on different bandwidths
3.6 Conclusion
In this research work, we proposed a new multivariate cure rate estimator under
random censoring when the cure rate is a function of covariates. This estimator in
fact is an extension to Xu and Peng [24] estimator. In this research work, the kernel
smoothing is used into the eigenvector equation to give us a smoother estimator.
One of the advantages of this estimator, compared to Tsodikov method [21], is
that it is applicable on discrete and continuous covariates. In this chapter, not only
the asymptotic distribution of the model has been found but also the optimal order
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Chapter 4
A Nonparametric Test for the
Presence of Immunes in the
Univariate Case
4.1 Introduction
In time-to-event data, there is a possibility that immunes exist. The presence of
immune individuals has an important role in the analysis of survival data. Cured or
immune individuals are defined as the ones who are not subject to the event of interest
(e.g. death). Since we consider only a specific period of time, there is censoring in
the study, which is one of the most important issues in survival analysis.
Let Xi, 1 ≤ i ≤ n, be independent and identically distributed (iid), non-negative
random variables, each having distribution function F (x) = P (X ≤ x) and survival
function S(x) = F¯ (x) = P (X ≥ x). There are also an independent set of censoring
variable Yi, 1 ≤ i ≤ n, with distribution function G. Assume that we observe
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Zi = min(Xi, Yi), δi = I(Xi ≤ Yi) 1 ≤ i ≤ n,
Consider the following model
F (t) = (1− p)F0(t),
where F0(t) is the baseline survival function and p is the probability of cure. As
discussed in Chapter 2, Maller and Zhou [11] proposed pˆ = 1− Fˆn(tn) as a consistent
estimator for p, where Fˆn(·) is the Kaplan-Meier estimator of F (·) and tn is the











for t > 0.
Since the limiting variance depends on p, a question arises here that what happens
if there is no cure rate in the model. If p = 0, the limiting distribution is degenerate
so it is important to test the existence of cure rate in the model. Maller and Zhou
[12] addressed this problem with the following null hypothesis,
H0 : p = 0, against H1 : p > 0.
They assumed that baseline survival function is the exponential survival function
with parameter λ. θˆ = (pˆ, λˆ) is the maximum likelihood estimates (MLE) under the
mixture model and θˆ0 is the MLE under H0. They introduced dn = −2(ln(θˆ0) −
ln(θˆ)) statistic to test the null hypothesis, where ln is the log-likelihood function.
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The limiting null distribution of the test-statistic was found to be a 50-50 mixture
distribution of chi-square random variable with 1 degree of freedom and a probability







P (χ2l ≤ C1−α) = 1− α.
In most of the studies the presence of cured patients was studied under the gamma
distribution. Peng et al. [16] did a simulation study to find the asymptotic null
distribution of the likelihood ratio test (LRT) for presence of cured patients under
Weibull and log-normal mixture models. They found that the results from Weibull,
log-normal and gamma are very close to each other and they have approximately the
same asymptotic null distribution.
In 2007, Sen and Tan [19] considered a nonparametric estimator of cure rate under
the mixture model and Case-1 interval censoring. Their proposed estimator is based
on the non-parametric MLE and degenerates like Maller and Zhou’s [11], when there
is no cure in the model.
In this chapter, we propose a test-statistic for the hypothesis of no cure, based on
Poisson convergence of censored empirical processes when the F is in the max domain
of attraction of some extreme-value distribution.
4.2 The Proposed Test-statistic
First we need to consider some assumptions.




has a non-degenerate limit distribution G0 as n → ∞. This
means that for every continuity point x of G0 we have
lim
n→∞F
n(anx+ bn) = G0(x),
where G0 is an extreme value distribution (EVD). Consequently,
lim
n→∞(1−
n(1− F (anx+ bn))
n
)n = G0(x),
for every continuity point x of G0. It follows that
lim
n→∞n(1− F (anx+ bn)) = − logG0(x).
Theorem 4 If (1 − G) = (1 − F )α (Koziol-Green model) for some α > 0, and if
there are constants an(α) > 0, bn(α) such that
n
(







Then under the assumption of no cure rate in the model (H0 : p = 0),
i) Nn(x) =
∑n
j=1 I(Zj ≥ an(α)x+ bn(α)) d−→ N ′(x) where N ′(.) is a Poisson process
with mean (− logG0(.))α+1,
ii) N1n(x) =
∑n
j=1 δjI(Zj ≥ an(α)x + bn(α)) d−→ N ′1(x) and N ′1(x) d=
∑N ′(x)
j=1 ηj,
where η1, η2, ... are iid with Bernoulli distribution with mean
1
α+1
= E(δ) and it can








i) For proof, see Charras and Lezaud [3] and Embrechts et al. [7].
ii) and iii) For proof, see Sen and Tan [19].

Theorem 5 Under the null hypothesis of no cure rate and previous assumptions,




i=1 δiI(Zi ≥ xn)∑n
i=1 I(Zi ≥ xn)
− cˆ
)√∑n
i=1 I(Zi ≥ xn)
cˆ(1− cˆ) → N(0, 1),





i=1 δi, provided xn is chosen to satisfy as n → ∞, xn → ∞
and n(1 − F (xn)) → ∞. Furthermore, if Tn < −zα, where P (N(0, 1) < −zα) = α,
the null hypothesis is rejected.
Note that we are yet to find a method for optimal choice of xn.
Proof: Note that the weak convergence in Theorem 4 can actually be strengthened
to a strong convergence as follows.
Based on the Theorem 2 in Sen and Tan [19], one can construct a sequence of
Poisson processes N ′1 and N
′ on R× R such that as n→∞,
sup
x
|N1n(x)−N ′1(x)| → 0,
sup
x






i=1 I(Zi ≥ xn)
cˆ(1− cˆ)
(∑n
i=1 δiI(Zi ≥ xn)∑n


























By Theorem 3, part (a) of Sen and Tan [19], as n→∞, (− logG0(x′n))α+1 →∞ and
N ′(x′n)












A sample of n = 200 independent random variables, Xi from Exponential(1) and
Yi from Exponential(0.5) are randomly selected. The following graph shows how Tn
behaves for different values of p when F ≈ Exp(1) and G ≈ Exp(0.5).
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Figure 4: The behaviour of Tn(x) when p = 0, F ≈ Exp(1) and G ≈ Exp(0.5)
Figure 5: The behaviour of Tn(x) when p = 0.25, F ≈ Exp(1) and G ≈ Exp(0.5)
We also applied the proposed statistic to the data from AMS study [8]. Twenty-six
eligible patients are randomly assigned to receive either maintenance chemotherapy
or to receive no maintenance therapy. The proposed statistic is illustrated on this
data as follows:
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Figure 6: The behaviour of Tn(x) for AML data (Non-Maintained)
Figure 7: The behaviour of Tn(x) for AML data (Maintained)
In Figure 7, although all the values of Tn are greater than -1.96, for α = 0.05, and
the null hypothesis cannot be rejected for the maintained AML data, we should note
that all Tn values are below zero, as is expected when cure-rate is positive. In both
AML maintained and non-maintained data, sample sizes are too small, so nothing
can be concluded conclusively.
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4.4 Conclusion
In this chapter, we proposed a test for the absence of a cure rate. Our approach
is based on Poisson convergence of censored empirical processes. We proposed a new
test-statistic to test the existence of cure in the study. Our proposed statistic has
a normal distribution with mean of zero and variance of one. A simulation is also
conducted to see the behaviour of proposed statistic.
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In Chapter 2, we proposed a new non-parametric multivariate cure rate estimator
under random censoring. We found that its asymptotic distribution is normal and we
proposed a variance estimator applicable under the sufficient follow-up condition. It
is demonstrated that the proposed model is robust and can be easily calculated. A
simulation study is conducted to support the theoretical results. We applied our pro-
posed model to the data from the Litter-matched tumorigenesis experiment [14]. The
estimation of cure rate and variance for the Litter-matched tumorigenesis experiment
are obtained.
In Chapter 3, a new multivariate cure rate estimator with covariates under ran-
dom censoring is considered. The proposed estimator is based on the non-parametric
approach and in fact, it is the extension of Xu and Peng [24] estimator to the mul-
tivariate survival time. Using cross-validation, the asymptotic distribution, variance
estimator and the optimal order of bandwidth for the proposed multivariate cure rate
estimator are obtained. A kernel smoothing method has been used to smooth the
proposed estimator.
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In Chapters 2 and 3, the asymptotic distribution and covariance functions of the
estimator have been obtained assuming that immunes exist. If the immunes do not
exist, limiting distribution is degenerate, so it is very important to find out if the
cure rate exists. In Chapter 4, a test-statistic regarding the presence of immunes in
the univariate case is proposed and the limiting distribution of the test-statistic is
obtained based on Poisson convergence of censored empirical processes and extreme
value theory.
5.2 Suggestion for Future Research
One of the suggested future work is to use Chaubey-Sen Poisson smoothing method
[4] instead of kernel smoothing in estimation of the nonparametric multivariate cure
rate with covariates. Their proposed method has solved many issues which exist in
the other methods.
The kernel smoothing method can be used for estimating functions with non-
negative random variables such as survival function and hazard function. In kernel
smoothing, some modifications have to be applied on the kernel to avoid the possible
probability of negative values. These lead to affect the bias and rate of convergence.
However, in Chaubey-Sen smoothing method, this condition is eliminated.
Another restriction of using kernel smoothing is the boundedness of the second
derivative of the density function which in Chaubey-Sen smoothing model, is not
necessary.
In the future, the proposed estimator can be applied on the first-hand survival-
analysis data where cure is a possibility, such as criminal recidivism, smoking cessa-
tion, etc.
In this thesis, simulations are presented for illustrative purposes and the strength
of the whole thesis lies on the theoretical aspects. Potential tests such as finite
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sample normality assessment and coverage tests for confidence intervals could be
added to the list of potential future work. Another potential work could be to use
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